Skip to content

Acute Rehabilitation in Patients With COVID-19 Pneumonia

Acute Rehabilitation in Patients With COVID-19 Pneumonia a Single Center Experience From a Developing Country

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05619666
Enrollment
200
Registered
2022-11-17
Start date
2021-09-01
Completion date
2023-01-31
Last updated
2022-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Physical Medicine, Rehabilitation

Keywords

Acute rehabilitation, COVID-19 pneumonia

Brief summary

COVID-19 can have different clinical manifestations including myalgia, arthralgia, neurological, cardiac, psychological and other manifestations.These patients are at greater risk of developing consequences of prolonged bed rest. Therefore physical medicine and rehabilitation could have an important role in the multidisciplinary treatment of these issues. Early respiratory and neuromuscular rehabilitation is necessary to improve functional physical limitations, performance, muscle strength, endurance as well as cognitive and emotional domains. Some studies proposed that rehabilitation protocols in the inpatient setting include early mobilisation, strength and endurance training with the aim of reducing weakness and dependency. This Study aimed to detect the effects of rehabilitation in patients with Covid-19 who were admitted in temporary Covid hospital in Serbia. Furthermore, to emphasize the importance of functional assessment of the patients, in identifying their problems and selections of priorities in planning the best therapeutic protocol.

Interventions

PROCEDUREAcute rehabilitation program

Patients included in the study started the rehabilitation program when they were hemodynamic stable, when it was determined that it was safe for patients. Until discharge from the hospital, a re-evaluation of neuromuscular and respiratory function was performed.

Sponsors

Institut za Rehabilitaciju Sokobanjska Beograd
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Positive pharyngeal or nasal swab for SARS CoV-2, 3) SP O2\> 94% on admission, 4) body temperature under 37.5 5) Clinical stability defined by ability to perform bedside active mobilization without a reduction of oxygen saturation (SpO2) below 92%;

Exclusion criteria

* 1\) SP o2 \< 94% on admission, 2) Moderate and severe heart failure (grade III and IV, NY heart Association), 3) Paresis or plegia as a result of CVI or neurodegenerative disease, 4) Impaired cognitive status.

Design outcomes

Primary

MeasureTime frameDescription
functional outcome of activity of daily livingup to three weeksBartel index (BI)
functional outcome of cardiovascular and respiratory systemup to three weekssix minute walk test (6MWT)
functional outcome for assesing dyspneaup to three weeksBorg scale for dyspnea,
functional outcome of mobilityup to three weeksTime Up and Go test (TUG)
functional outcome of lower limbs strengthup to three weeksSit To Stand test (STS)
functional outcome of static balanceup to three weeksOne Leg Stance Test (OLST)

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026